2937.12.00.00/Insulin Glulisine (Apidra)/Canada

Insulin Glulisine (Apidra) from Canada

Ultra-rapid acting insulin analogue with glycine/lysine modifications at B-chain. HTS 2937.12.00.00 covers rDNA-produced structural analogues used primarily as polypeptide hormones.

Duty Rate — Canada → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Sequence analysis certificate confirming glulisine modifications essential

• Maintain refrigerated conditions; ultra-rapid analogues have narrow stability window

• API vs finished product distinction critical for correct HTS classification